Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RWLK | Ordinary Shares, par value NIS 0.25 per share | Sale | -$6.32K | -4.13K | -4.55% | $1.53 | 86.5K | Nov 15, 2021 | By Partnership | F1, F2 |
Id | Content |
---|---|
F1 | The disposed of securities consist of 2,480 ordinary shares sold by Vitalife Partners (Overseas) L.P. ("Vitalife Partners Overseas"), 820 ordinary shares sold by Vitalife Partners (Israel) L.P. ("Vitalife Partners Israel") and 829 ordinary shares sold by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners D.C.M"). The shares were disposed of in connection with the termination of the funds. |
F2 | Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 55,874 ordinary shares of the Company. |